Neogen Corporation is set to report its first quarter earnings before markets open on Thursday, January 8, 2025, and Wall Street’s most accurate analysts have made notable revisions to their revenue and earnings outlooks. Jefferies raised its quarterly revenue estimate by 3.2%, projecting $148 million driven by stronger sales in food safety reagents, while boosting its adjusted EBITDA forecast by 4.7% to $35 million. RBC Capital Markets increased its full-year revenue growth projection to 9.5%, up from 8.2%, citing robust international demand for animal safety assays. Citi analyst forecasts for non-GAAP EPS climbed by 5.1% for the quarter to $0.45, reflecting operational efficiencies realized in Neogen’s Lansing, Michigan production facilities.

Neogen today announced the appointment of Joe Freels as Senior Vice President and Chief Commercial Officer, effective January 5, 2026, and Dr. Tammi Ranalli as Senior Vice President and General Manager, Global Food Safety, effective January 7, 2026. Mr. Freels will oversee worldwide commercial strategy across Neogen’s animal safety and food safety segments, managing a sales team of more than 200 representatives. Dr. Ranalli will assume full P&L responsibility for the global Food Safety portfolio, which generated $520 million in revenue last fiscal year, and will lead product innovation and market expansion in over 70 countries.